Perbedaan Japfa Comfeed Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Japfa Comfeed Indonesia Tbk. diperdagangkan di Rp2.250 (kapitalisasi pasar 27,21 T, volume 24 jam 21,43 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Japfa Comfeed Indonesia Tbk. jauh lebih besar — sekitar 163,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Japfa Comfeed Indonesia Tbk. lebih aktif diperdagangkan (21,43 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| JPFA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 27,21 T | 166,01 M |
Volume | 21,43 jt | 324 rb |
Lot | 214,28 rb | 3,24 rb |
Perputaran | 48,33 M | 77,68 jt |
Harga Rata-rata | 2.255,47 | 239,75 |
Nilai Transaksi | 48,33 M | 77,68 jt |
Harga Ekuilibrium Indikatif | 2.250 | 240 |
Volume Ekuilibrium Indikatif | 16,2 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Selengkapnya di halaman JPFA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →